Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01315665 · ClinicalTrials.gov registry record · NA
Effect of Sulforaphane in Broccoli Sprouts on Nrf2 Activation
A NA study, sponsored by University Hospitals Cleveland Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT01315665 is a NA study that has completed, run by University Hospitals Cleveland Medical Center. The registered enrollment target is 15 participants.
The verdict
NCT01315665, a NA study, has completed, sponsored by University Hospitals Cleveland Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
The purpose of this study to investigate the effect of sulforaphane from macerated broccoli sprouts in humans and to evaluate less invasive methods of assessing potential anti-inflammatory drugs in CF.
Interventions
- DIETARY_SUPPLEMENT Broccoli sprouts
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2011-04 |
| Est. Completion | 2013-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01315665
The ClinicalTrials.gov registry entry for NCT01315665 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University Hospitals Cleveland Medical Center, which has 230 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Broccoli sprouts is the first listed.
NCT01315665 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01315665 about?
NCT01315665 is a clinical study titled "Effect of Sulforaphane in Broccoli Sprouts on Nrf2 Activation". The purpose of this study to investigate the effect of sulforaphane from macerated broccoli sprouts in humans and to evaluate less invasive methods of assessing potential anti-inflammatory drugs in CF.
What is the current status of trial NCT01315665?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2011-04. Estimated completion is 2013-02.
What interventions are being tested in trial NCT01315665?
The interventions under investigation include: Broccoli sprouts (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01315665?
This trial is sponsored by University Hospitals Cleveland Medical Center, which has 230 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.